Blueprint Medicines Corp (BPMC)
129.46
0.00 (0.00%)
USD |
NASDAQ |
Aug 13, 16:00
Blueprint Medicines 1 Year Total Returns (Daily)
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 13, 2025 | 39.47% |
| August 12, 2025 | 38.15% |
| August 11, 2025 | 37.87% |
| August 08, 2025 | 41.58% |
| August 07, 2025 | 42.50% |
| August 06, 2025 | 39.59% |
| August 05, 2025 | 39.25% |
| August 04, 2025 | 33.85% |
| August 01, 2025 | 29.09% |
| July 31, 2025 | 19.54% |
| July 30, 2025 | 20.96% |
| July 29, 2025 | 17.33% |
| July 28, 2025 | 15.39% |
| July 25, 2025 | 13.87% |
| July 24, 2025 | 12.59% |
| July 23, 2025 | 10.70% |
| July 22, 2025 | 10.83% |
| July 21, 2025 | 12.60% |
| July 18, 2025 | 14.10% |
| July 17, 2025 | 13.20% |
| July 16, 2025 | 7.29% |
| July 15, 2025 | 8.22% |
| July 14, 2025 | 9.83% |
| July 11, 2025 | 9.77% |
| July 10, 2025 | 11.54% |
| Date | Value |
|---|---|
| July 09, 2025 | 11.54% |
| July 08, 2025 | 10.39% |
| July 07, 2025 | 14.95% |
| July 03, 2025 | 17.72% |
| July 02, 2025 | 16.17% |
| July 01, 2025 | 17.55% |
| June 30, 2025 | 18.93% |
| June 27, 2025 | 18.05% |
| June 26, 2025 | 23.32% |
| June 25, 2025 | 20.37% |
| June 24, 2025 | 20.89% |
| June 23, 2025 | 23.19% |
| June 20, 2025 | 21.85% |
| June 18, 2025 | 20.06% |
| June 17, 2025 | 23.45% |
| June 16, 2025 | 21.51% |
| June 13, 2025 | 20.27% |
| June 12, 2025 | 20.79% |
| June 11, 2025 | 21.40% |
| June 10, 2025 | 23.01% |
| June 09, 2025 | 23.83% |
| June 06, 2025 | 22.44% |
| June 05, 2025 | 20.87% |
| June 04, 2025 | 25.72% |
| June 03, 2025 | 21.71% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Agenus, Inc. | 74.41% |
| Amgen, Inc. | 44.20% |
| Altimmune, Inc. | -9.43% |
| Amarantus Bioscience Holdings, Inc. | 0.00% |
| Aligos Therapeutics, Inc. | -48.15% |